VIR
Vir Biotechnology, Inc.
Halal Rating :
See Details
Last Price
$9.34
Last updated:
Market Cap
$1.73b
7D Change
-17.15%
1 Year Change
-51.39%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Nov. 2, 2023
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2023 | $3.8m | $218.96m | $23.02m | - | 606.16% | 0.00% |
| March 31, 2023 | $62.96m | $204.55m | $21.31m | $0.24 | 33.84% | 0.12% |
| Dec. 31, 2022 | $49.41m | $194.02m | $16.17m | $9.72m | 32.73% | 5.01% |
Company Impact
Help us evaluate Vir Biotechnology, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.